Curated for Orthogate.org Members

EXECUTIVE SUMMARY

• Remex Medical Receives FDA 510(k) Clearance for Remex Spine Surgery Navigation Platform: Remex Medical Corp. received FDA clearance for its Universal Instruments spine navigation system, providing open-architecture stereotaxic instrumentation across multi-vendor pedicle screw systems.
• Surgical Navigation Systems Market Accelerates at 14.4% CAGR Toward Outpatient Migration: Market intelligence reported by OrthoSpineNews projects robust growth in stereotaxic surgical navigation driven by expanding adoption in ambulatory surgery centers (ASCs).
• Globus Medical Integrates AI-Driven Care Management Following Higgs Boson Health Acquisition: Globus Medical is integrating Duke-incubated Higgs Boson Health's software with its ExcelsiusGPS® robotics suite to manage perioperative episodes of care.

DAILY ANNOUNCEMENTS BY CATEGORY

Surgical Robotics, AI & Navigation

Remex Medical — FDA 510(k) Clearance Granted for Spine Surgery Navigation Universal Instruments

• Summary: Remex Medical Corp. obtained FDA 510(k) clearance (K262506) for its Remex Spine Surgery Navigation - Universal Instruments platform. Classified as an Orthopedic Stereotaxic Instrument (Product Code OLO), the system provides tracked universal navigation instruments compatible with multiple third-party pedicle screw systems and intraoperative imaging modalities, enabling precise trajectory guidance without proprietary implant locking.
• Key Details:
  • Device/System Name: Remex Spine Surgery Navigation - Universal Instruments
  • Status: FDA 510(k) Cleared (K262506)
  • Clinical Significance: Provides open-platform stereotaxic guidance, reducing hospital capital lock-in and improving pedicle screw placement accuracy during minimally invasive spine surgery.
• Original Source: FDA 510(k) Premarket Notification Database

OrthoSpineNews / Market Report — Surgical Navigation Systems Market Projected at 14.4% CAGR Through 2030

• Summary: A market intelligence report published by OrthoSpineNews details accelerating demand for orthopaedic and spine surgical navigation systems, projecting a 14.4% compound annual growth rate through 2030. Key growth drivers include the migration of total joint arthroplasty and spinal instrumentation into ambulatory surgery centers (ASCs), where lightweight optical and CT-free navigation platforms offer sub-millimeter precision without the high capital footprint of full robotic consoles.
• Key Details:
  • Device/System Name: Orthopaedic & Spine Surgical Navigation Platforms
  • Status: Industry Market Intelligence Report
  • Clinical Significance: Highlights expanding adoption of cost-effective, space-efficient stereotaxic guidance in outpatient total joint and spine procedures.
• Original Source: OrthoSpineNews Surgical Navigation Market Report

Corporate, M&A & Digital Health

Globus Medical — Completes Acquisition of Higgs Boson Health to Expand Digital Care Ecosystem

• Summary: Globus Medical, Inc. (NYSE: GMED) announced the acquisition of Higgs Boson Health, a Durham, NC-based digital health company incubated out of Duke University. The integration pairs Higgs Boson's AI-enabled patient engagement and perioperative navigation platform with Globus Medical's ExcelsiusGPS® surgical robotics and implant ecosystems, providing continuous digital care management across the full episode of surgical care.
• Key Details:
  • Device/System Name: Higgs Boson Digital Health Platform & ExcelsiusGPS® Ecosystem
  • Status: Strategic M&A Completed
  • Clinical Significance: Connects preoperative patient preparation and remote postoperative functional tracking directly with intraoperative surgical navigation data.
• Original Source: Globus Medical Acquisition Announcement — GlobeNewswire

Sports Medicine & Clinical AI

AMSSM & OpenEvidence — Exclusive Partnership to Co-Develop AI Sports Medicine Clinical Resources

• Summary: The American Medical Society for Sports Medicine (AMSSM) and OpenEvidence announced a strategic partnership to co-develop dedicated AI-powered point-of-care clinical decision support tools and patient educational resources. The platform integrates AMSSM's clinical practice guidelines, position statements, and expert sports medicine publications directly into OpenEvidence's clinical AI search interface.
• Key Details:
  • Device/System Name: AMSSM / OpenEvidence Sports Medicine Clinical AI Platform
  • Status: Strategic Educational & Clinical AI Partnership
  • Clinical Significance: Equips sports medicine specialists and orthopaedic surgeons with rapid, evidence-grounded decision support for acute musculoskeletal injury management and return-to-sport clearance.
• Original Source: AMSSM & OpenEvidence Partnership Announcement — OrthoSpineNews

Spine & Sacro-Pelvic Reconstruction

Tenon Medical — Closes $3M Private Placement to Accelerate Catamaran® SI Joint Fusion Commercialization

• Summary: Tenon Medical, Inc. (NASDAQ: TNON) completed a $3.0 million private placement offering of common stock and warrants at an effective price of $5.02 per share. The proceeds will fund nationwide commercial distribution, surgeon education, and clinical evidence initiatives for the Catamaran® Sacroiliac (SI) Joint Fusion System.
• Key Details:
  • Device/System Name: Catamaran® SI Joint Fusion System
  • Status: Private Placement Financing ($3.0M)
  • Clinical Significance: Expands surgeon training and access for single-transfixion posterior-inferior sacroiliac joint stabilization in outpatient spine surgery.
• Original Source: Tenon Medical Private Placement Announcement — OrthoSpineNews

NEW FDA 510(k) & PMA CLEARANCE LISTING (PAST 24–48 HOURS)